Can Gallbladder Removal Cause Fatty Liver?

Gallbladder removal, or cholecystectomy, is one of the most common surgical procedures performed in the UK, but many patients wonder whether it can cause fatty liver disease. While cholecystectomy does not directly cause fatty liver, research suggests it may be associated with a modestly higher risk in people who already have underlying metabolic risk factors. Understanding how bile flow changes after surgery, what symptoms to watch for, and how to protect your liver through lifestyle choices can help you make informed decisions about your health after gallbladder removal.

Can removing your gallbladder lead to fatty liver disease?

Gallbladder removal does not directly cause fatty liver disease, but it is associated with a modestly higher risk, particularly in people who already have metabolic risk factors such as obesity or insulin resistance.

Gallbladder removal (cholecystectomy) does not directly cause fatty liver disease, but observational research suggests it may be associated with a modestly higher likelihood of developing the condition in some individuals, particularly when other metabolic risk factors are already present. The gallbladder stores and concentrates bile produced by the liver, releasing it in controlled bursts during meals to aid fat digestion. Once the gallbladder is removed, this regulated release is lost, and bile flows continuously into the small intestine regardless of food intake.

Several observational studies and meta-analyses have reported an association between cholecystectomy and a higher likelihood of developing non-alcoholic fatty liver disease (NAFLD, now increasingly termed metabolic dysfunction-associated steatotic liver disease or MASLD).^[1][2] The terminology shift from NAFLD to MASLD reflects an international consensus, adopted in UK specialist practice, that better captures the metabolic drivers of the condition.^[3] However, it is important to note that the conditions that lead to gallstones in the first place, such as obesity, insulin resistance, and metabolic syndrome, are themselves well-established risk factors for fatty liver. Disentangling the effect of surgery from these pre-existing factors is clinically challenging, and the association seen in studies may partly reflect shared underlying risk rather than a direct effect of the operation.

The current evidence does not establish cholecystectomy as an independent cause of fatty liver in otherwise healthy individuals. Rather, the surgery may act as one contributing factor within a broader metabolic picture. If you have concerns about your liver health following gallbladder removal, speaking with your GP is the appropriate first step.

How does bile flow change after a cholecystectomy?

After cholecystectomy, bile flows continuously from the liver into the small intestine rather than being stored and released at mealtimes, disrupting the enterohepatic circulation and potentially affecting how the liver processes fats.

After cholecystectomy, bile flows continuously and directly from the liver into the small intestine rather than being stored and released in response to meals. Under normal circumstances, the gallbladder concentrates bile and delivers it in a coordinated surge when dietary fat is detected, optimising fat emulsification and absorption. Without this reservoir, the liver adjusts bile acid synthesis over time, but the timing and concentration of bile reaching the gut changes substantially.

This altered bile acid metabolism may have downstream effects. Continuous bile delivery means that between meals, when fat intake is low, bile acids may be reabsorbed more rapidly from the small intestine. This can affect the enterohepatic circulation, the recycling loop through which bile acids travel from the gut back to the liver. Research suggests that disruption of this cycle may influence how the liver processes fats and cholesterol, though whether this directly contributes to lipid accumulation in liver cells over time remains an area of ongoing investigation rather than an established causal pathway.^[4][5]

Changes in bile acid composition and flow may also influence the gut microbiome, which plays a role in metabolic regulation. Shifts in microbial populations following cholecystectomy have been documented in research settings, though the clinical significance of these changes for liver health in individual patients is not yet clearly established.^[7][8] These physiological observations help explain why some people may be more vulnerable to metabolic liver changes after surgery, even if the surgery itself is not the sole or direct cause.

What are the risk factors for developing fatty liver after surgery?

The greatest risk is in people who already have obesity, type 2 diabetes, insulin resistance, high triglycerides, or metabolic syndrome before surgery, as these conditions independently predispose to fatty liver disease.

The people most likely to develop fatty liver after gallbladder removal are those who already carry established metabolic risk factors before their operation. These include:

• Obesity or overweight, particularly with central (abdominal) adiposity

• Type 2 diabetes or insulin resistance

• High triglyceride or low HDL cholesterol levels

• A diet high in refined carbohydrates, ultra-processed foods, or excess saturated fat

• Physical inactivity

• Alcohol consumption above low-risk levels (more than 14 units per week, per UK Chief Medical Officers' guidance)^[10]

Gallstones themselves are strongly associated with metabolic syndrome, meaning many people undergoing cholecystectomy already have one or more of these risk factors at the time of surgery. This overlap makes it difficult to attribute subsequent fatty liver disease solely to the procedure.

Age and sex also play a role. Fatty liver disease is more common in middle-aged adults, and some evidence suggests that hormonal changes around the menopause may increase susceptibility in women, though this relationship is not fully characterised and should be interpreted cautiously.

Rapid weight loss following surgery, sometimes seen when patients change their diet after gallbladder removal, can transiently worsen liver fat accumulation by mobilising large amounts of fatty acids to the liver simultaneously.^[13] It is worth noting that sustained, gradual weight loss generally improves MASLD over time; the concern applies specifically to very rapid or crash-diet approaches.

Genetic factors, including variants in genes such as PNPLA3 and TM6SF2, are recognised to influence individual susceptibility to fatty liver disease and may help explain why some post-cholecystectomy patients develop liver changes while others do not.^[11][12] A thorough medical history and metabolic assessment before and after surgery can help identify those who would benefit from closer monitoring.

Signs and symptoms of fatty liver you should know about

Fatty liver disease is often asymptomatic early on, but may cause persistent fatigue or upper right abdominal discomfort; jaundice, abdominal swelling, or severe confusion require prompt medical attention.

Fatty liver disease is frequently asymptomatic in its early stages, meaning many people are unaware they have it until it is detected incidentally during investigations for another condition. When symptoms do occur, they tend to be non-specific and easy to attribute to other causes, which is why awareness is important for anyone with known risk factors, including those who have had a cholecystectomy.

Symptoms that may suggest fatty liver include:

• Persistent fatigue or low energy that is disproportionate to activity levels

• A dull ache or discomfort in the upper right abdomen, where the liver sits

In more advanced disease, where significant inflammation (metabolic-associated steatohepatitis, MASH) or fibrosis has developed, additional signs may appear, including:

• Jaundice (yellowing of the skin or whites of the eyes)

• Swelling of the abdomen or legs

• Easy bruising or bleeding

• Confusion or difficulty concentrating in severe cases

If you experience jaundice or significant abdominal swelling, contact your GP promptly or call NHS 111 for advice. If you develop severe confusion or drowsiness, vomit blood, or notice black tarry stools, call 999 or go to your nearest emergency department immediately, as these may indicate serious liver or gastrointestinal complications requiring urgent assessment.

For anyone with multiple metabolic risk factors, NICE guidance (NG49) recommends a risk-stratified approach to liver assessment rather than relying on liver function tests alone.^[14][15] Your GP can advise on whether further assessment is appropriate for you.

How is fatty liver diagnosed and managed after gallbladder removal?

Diagnosis uses liver function tests, FIB-4 scoring, and imaging such as FibroScan, following NICE guidance (NG49); management focuses on weight loss, metabolic risk factor control, physical activity, and alcohol reduction.

Fatty liver disease is most commonly identified through a combination of blood tests and imaging, and the same diagnostic approach applies whether or not a person has had a cholecystectomy. Liver function tests (LFTs) may show elevated alanine aminotransferase (ALT) or aspartate aminotransferase (AST), though these can be normal even when significant fat is present. A fasting lipid profile and blood glucose or HbA1c test help assess the broader metabolic picture.

NICE guidance (NG49) recommends a stepwise, non-invasive approach to fibrosis assessment. In primary care, a FIB-4 score or NAFLD Fibrosis Score (NFS) is typically calculated first using routine blood results and clinical data. Those with an intermediate or high score are then referred for second-line assessment, which may include an Enhanced Liver Fibrosis (ELF) blood test or FibroScan (transient elastography), before liver biopsy is considered. Ultrasound of the abdomen remains a widely used first-line imaging investigation and can detect increased echogenicity consistent with hepatic steatosis, but it does not reliably assess fibrosis severity.

Management of fatty liver after cholecystectomy follows the same evidence-based principles as for MASLD in the general population. At the time of writing, there is no pharmacological treatment licensed specifically for MASLD or MASH in the UK; readers should check current NICE technology appraisals and MHRA guidance for any updates, as this is an active area of drug development.^[16][17] Management therefore centres on addressing underlying metabolic risk factors. This includes:

• Weight management, with evidence from clinical trials and NICE supporting a target of around 7 to 10% body weight reduction to meaningfully reduce liver fat^[14]

• Optimising blood glucose and lipid control

• Reducing or eliminating alcohol intake

• Structured physical activity

Your GP can refer you to a hepatologist or specialist liver service if investigations suggest significant fibrosis, if your FIB-4 or NFS score is in the intermediate or high range, or if your condition is not responding to lifestyle measures. Bolt Pharmacy is a GPhC-registered UK online pharmacy offering online consultations, with prescriber review and pharmacist support, for those seeking guidance on metabolic health alongside their primary care team.

Lifestyle changes that can protect your liver after a cholecystectomy

Eating smaller, more frequent meals, reducing saturated fat and refined carbohydrates, taking regular physical activity, and achieving gradual weight loss are the most effective lifestyle strategies to protect liver health after cholecystectomy.

Adopting targeted lifestyle changes after gallbladder removal is one of the most effective ways to reduce the risk of fatty liver disease and support overall metabolic health. Because the altered bile flow that follows cholecystectomy affects fat digestion and liver metabolism, dietary adjustments are particularly important in the weeks and months after surgery, and ideally maintained long term. NHS aftercare guidance for cholecystectomy recommends eating smaller, more frequent meals in the initial recovery period; this approach may also be helpful longer term for managing continuous bile flow, though individual tolerance varies.^[23]

Dietary recommendations include:

• Eating smaller, more frequent meals rather than large portions, to reduce the burden on continuous bile flow

• Reducing intake of saturated fats, trans fats, and ultra-processed foods

• Increasing dietary fibre through vegetables, legumes, wholegrains, and fruit, which supports gut health and bile acid regulation

• Limiting added sugars and refined carbohydrates, which contribute to hepatic fat accumulation

• Staying well hydrated with water rather than sugary drinks

Physical activity plays an equally important role. Both aerobic exercise (such as brisk walking, cycling, or swimming) and resistance training have been shown in clinical studies to reduce liver fat, including independently of weight loss.^[18][19] UK Chief Medical Officers' physical activity guidelines recommend at least 150 minutes of moderate-intensity activity per week for adults, alongside muscle-strengthening activity on two or more days per week.^[21][22]

Alcohol should be kept within the UK Chief Medical Officers' low-risk guidelines of no more than 14 units per week, spread across several days, with several alcohol-free days included each week. For those with existing liver changes, abstinence may be advisable, and your GP can provide personalised guidance.

Weight management is central to liver protection. Even a modest, sustained reduction in body weight of 5 to 10% can meaningfully reduce hepatic steatosis.^[13][14] Crash dieting or very rapid weight loss should be avoided, as this can transiently worsen liver fat by flooding the liver with mobilised fatty acids. A gradual, sustainable approach supported by a dietitian or structured weight-management programme is preferable, and your GP can refer you to appropriate services.

Scientific References

1. Cholecystectomy and risk of liver disease: a systematic review and meta-analysis of 27 million individuals.
2. Association Between Cholecystectomy and Nonalcoholic Fatty Liver Disease: A Meta-analysis: Reply.
3. Understanding the evolving nomenclature of steatotic liver disease.
4. HFD Exacerbates Hepatic Lipid Metabolism Disorders After Cholecystectomy by Regulating the Bile Acid and Neutrophil Recruitment.
5. The Continuing Importance of Bile Acids in Liver and Intestinal Disease.
6. Potential far-reaching metabolic consequences of cholecystectomy.
7. Postcholecystectomy Gut Microbiome Changes and the Association with Liver Disease.
8. Cholecystectomy-induced gut dysbiosis and its consequences: bridging animal models and clinical outcomes in narrative review.
9. Cholecystectomy-associated gut microbiota dysbiosis promotes colorectal carcinogenesis: from epidemiological controversy to FXR-centered mechanistic insights.
10. Alcohol consumption: advice on low risk drinking – UK Chief Medical Officers' guidelines.
11. Genetic modulators of metabolic dysfunction-associated steatotic liver disease (MASLD) and their epistatic interactions: from in vitro and animal models to clinical outcomes.
12. UK Biobank-Based Genetic and Proteomic Network Insights into Metabolic Dysfunction-Associated Steatotic Liver Disease Pathogenesis.
13. Non-alcoholic fatty liver disease (NAFLD).
14. Metabolic dysfunction-associated steatotic liver disease (NG49).
15. Non-alcoholic fatty liver disease (NAFLD): summary of NICE guidance.
16. Resmetirom (Rezdiffra) authorised to treat metabolic dysfunction-associated steatohepatitis (MASH) in adults.
17. GID-TA11477 draft scope: no medicines currently approved for MASLD or MASH in the UK.
18. Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight change.
19. Structured Exercise Interventions and Hepatic-Metabolic Outcomes in Adults with MASLD: A Narrative Review of Randomized Controlled Trials.
20. Exercise improves surrogate measures of liver histological response in metabolic dysfunction-associated steatotic liver disease.
21. Physical activity guidelines: UK Chief Medical Officers' report.
22. Physical activity guidelines for adults aged 19 to 64.
23. Recovering from gallbladder removal.

Frequently Asked Questions